• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急变期慢性髓性白血病的分子特征

Molecular characteristics of chronic myelogenous leukemia in blast crisis.

作者信息

Blick M, Romero P, Talpaz M, Kurzrock R, Shtalrid M, Andersson B, Trujillo J, Beran M, Gutterman J

出版信息

Cancer Genet Cytogenet. 1987 Aug;27(2):349-56. doi: 10.1016/0165-4608(87)90018-5.

DOI:10.1016/0165-4608(87)90018-5
PMID:3474057
Abstract

We have studied the expression of c-abl and c-myc in leukemic cells of patients in all clinical phases of chronic myelogenous leukemia. We demonstrate that an aberrant 8-Kb c-abl related transcript is present in the RNA of the leukemic cell from all patients with Ph+ CML and that the loss of both normal chromosome #9 is associated with the loss of the normal c-abl related transcripts. This represents direct evidence that the normal c-abl related transcripts derive from the normal c-abl gene locus on the normal chromosome #9, while the aberrant c-abl related transcript in Ph+ CML derives from the hybrid bcr-abl gene formed as a result of the t(9;22). We further demonstrate that trisomy 8 in some instances is associated with enhanced expression of the c-myc oncogene.

摘要

我们研究了慢性粒细胞白血病所有临床阶段患者白血病细胞中c-abl和c-myc的表达。我们证明,在所有Ph+慢性粒细胞白血病患者的白血病细胞RNA中都存在一种异常的8千碱基c-abl相关转录本,并且两条正常9号染色体的缺失与正常c-abl相关转录本的缺失相关。这代表了直接证据,即正常c-abl相关转录本来自正常9号染色体上的正常c-abl基因位点,而Ph+慢性粒细胞白血病中的异常c-abl相关转录本来自因t(9;22)形成的融合bcr-abl基因。我们进一步证明,在某些情况下,8号染色体三体与c-myc癌基因的表达增强相关。

相似文献

1
Molecular characteristics of chronic myelogenous leukemia in blast crisis.急变期慢性髓性白血病的分子特征
Cancer Genet Cytogenet. 1987 Aug;27(2):349-56. doi: 10.1016/0165-4608(87)90018-5.
2
Heterogeneity in expression of the bcr-abl fusion transcript in CML blast crisis.
Leukemia. 1987 Oct;1(10):718-24.
3
Persistence of chronic myelocytic leukemia despite deletion of rearranged bcr/c-abl sequences in blast crisis.尽管在急变期重排的bcr/c-abl序列缺失,但慢性粒细胞白血病仍持续存在。
J Exp Med. 1986 Nov 1;164(5):1389-96. doi: 10.1084/jem.164.5.1389.
4
Chronic myelogenous leukemia: amplification of a rearranged c-abl oncogene in both chronic phase and blast crisis.慢性粒细胞白血病:在慢性期和急变期均存在重排的c-abl癌基因扩增。
Blood. 1987 Mar;69(3):893-8.
5
Acquired homozygosity of the rearranged bcr allele during the acute leukemic phase of a patient with Ph-negative chronic myeloid leukemia.Ph阴性慢性髓性白血病患者急性白血病阶段重排的bcr等位基因获得性纯合性。
Blood. 1988 Jul;72(1):24-8.
6
Transposition of c-abl oncogene in a case of masked Ph chromosome duplicated in blastic phase.一例急变期隐匿性Ph染色体重复病例中c-abl癌基因的易位
Hum Genet. 1988 Mar;78(3):248-50. doi: 10.1007/BF00291671.
7
[Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].[慢性粒细胞白血病向急变期转化的分子分析]
Hokkaido Igaku Zasshi. 1993 Mar;68(2):237-50.
8
Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.在慢性髓性白血病的髓系原始细胞危象中,LEF1/β-连环蛋白复合物通过p53改变激活EVI1转录。
Biochem Biophys Res Commun. 2017 Jan 22;482(4):994-1000. doi: 10.1016/j.bbrc.2016.11.146. Epub 2016 Nov 28.
9
Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.Bcr、Abl和Bcr-Abl蛋白在正常细胞和白血病细胞中的亚细胞定位以及表达与髓系分化的相关性。
J Clin Invest. 1993 Oct;92(4):1925-39. doi: 10.1172/JCI116786.
10
Polymorphism of the human c-abl gene: relation to incidence and course of chronic myelogenous leukemia.人类c-abl基因的多态性:与慢性粒细胞白血病的发病率及病程的关系
Oncogene. 1987 May;1(2):193-200.

引用本文的文献

1
Differential prognostic impact of stratified additional chromosome abnormalities on disease progression among Malaysian chronic myeloid leukemia patients undergoing treatment with imatinib mesylate.分层额外染色体异常对接受甲磺酸伊马替尼治疗的马来西亚慢性髓性白血病患者疾病进展的差异预后影响。
Front Oncol. 2022 Aug 8;12:720845. doi: 10.3389/fonc.2022.720845. eCollection 2022.
2
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene.BCR/ABL1和BCR受MYC癌基因的转录调控。
Mol Cancer. 2015 Jul 16;14:132. doi: 10.1186/s12943-015-0407-0.
3
A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation.
一条丝裂原活化蛋白激酶/不均一核糖核蛋白K(MAPK/HNRPK)信号通路通过调控MYC信使核糖核酸(mRNA)的翻译来控制BCR/ABL致癌潜能。
Blood. 2006 Mar 15;107(6):2507-16. doi: 10.1182/blood-2005-09-3732. Epub 2005 Nov 17.
4
Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.Bcr、Abl和Bcr-Abl蛋白在正常细胞和白血病细胞中的亚细胞定位以及表达与髓系分化的相关性。
J Clin Invest. 1993 Oct;92(4):1925-39. doi: 10.1172/JCI116786.
5
A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells.一种温度敏感的p210 BCR-ABL突变体确定了生长因子依赖性细胞中BCR-ABL酪氨酸激酶表达的主要后果。
EMBO J. 1994 Dec 15;13(24):5887-95. doi: 10.1002/j.1460-2075.1994.tb06934.x.